However, despite its status as the primary treatment for GBM, a significant portion of the population have normal expression of MGMT gene to MGMT protein, which is a repair enzyme which confers resistance to TMZ24,25, highlighting the need for rapid feedback to patient response to TMZ. The gene discussed is MGMT; the disease is glioblastoma.